The Small Animal Imaging Resource provides imaging using multiple modalifies including depth resolved or planar fluorescence and bioluminescent imaging, MRI, PET/CT, and planar scintigraphy. A number of experienced investigators and technical staff capable of undertaking imaging and assisfing in data interpretation are associated with the Resource. There is infrastructure for animal handling (e.g., anesthesia, infusion, monitoring vital signs) and can facilitate and undertake developmental studies for implementafion of new imaging protocols and evaluafion of methods. The Resource is supported by a radiochemistry laboratory and molecular synthesis laboratory and has computer capabilities for data analysis and archiving. The Small Animal Imaging Resource has been promofing and enhancing cellular and molecular imaging for the last 10 years and has developed substanfial infrastructure. Regular seminars and symposia have stimulated increasing interest among scienfists and physicians from diverse backgrounds (engineers, chemists, molecular biologists, and oncologists) to apply imaging to questions in oncology and this has been recognized by grants to several individuals. The Resource supported in part by a U24 SAIRP (Pis Ralph Mason and Dean Sherry) commenced in April 2007. The Resource serves as a catalyst for new collaborations and focus for coordinating new infrastructure, e.g., winning NIH Shared instrumentation grants for a Caliper (Xenogen) Spectrum in 2008 and Insfitutional investment in small animal MRI and PET/CT. Imaging (radiology) and histology (pathology) are the cornerstones of most clinical rounds and diagnoses. Increasingly, imaging is filtering down to small animal research, coinciding with the availability of opfimized imaging instrumentafion. There is a realization that progress in molecular biology and drug design must move to assessment in vivo. Imaging allows animals (tumors) to serve as their own controls, substanfially improving research efficiency. In many cases, animal models (e.g., transgenic and knockout) are exceedingly cosfiy and/or in short supply. Many reagents, e.g., novel therapeufic anfibodies are available only in small quantifies. Fewer animals are needed, saving on cost and meefing ethical goals for biomedical research. Thus, maximizing the information and quality of data obtained from individual subjects should enhance research efficiency and ulfimate translafion to the clinic.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
United States
Zip Code
Eskiocak, Banu; McMillan, Elizabeth A; Mendiratta, Saurabh et al. (2017) Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. Cancer Discov 7:832-851
Rutkowski, Joseph M; Pastor, Johanne; Sun, Kai et al. (2017) Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression. Kidney Int 91:324-337
Singh, Jaspal; Rustagi, Vineeta; Zhang, Shanrong et al. (2017) On-bead combinatorial synthesis and imaging of europium(III)-based paraCEST agents aids in identification of chemical features that enhance CEST sensitivity. Magn Reson Chem 55:747-753
Singh, Dinesh K; Kollipara, Rahul K; Vemireddy, Vamsidara et al. (2017) Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma. Cell Rep 18:961-976
Gu, Yi-Feng; Cohn, Shannon; Christie, Alana et al. (2017) Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade. Cancer Discov 7:900-917
Lee, Ming Y; Sumpter Jr, Rhea; Zou, Zhongju et al. (2017) Peroxisomal protein PEX13 functions in selective autophagy. EMBO Rep 18:48-60
Gao, Boning; Huang, Chunxian; Kernstine, Kemp et al. (2017) Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions. Oncotarget 8:11114-11126
Howard, James J; Sturge, Carolyn R; Moustafa, Dina A et al. (2017) Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers. Antimicrob Agents Chemother 61:
Skinner, Celette Sugg; Ahn, Chul; Halm, Ethan A et al. (2017) Recommendation of colorectal cancer testing among primary care patients younger than 50 with elevated risk. Prev Med 102:20-23
Garcia, Sandra; Bisen, Ajit; Yan, Jingsheng et al. (2017) Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity. J Thorac Oncol 12:1489-1495

Showing the most recent 10 out of 441 publications